Annual EBITDA:
-$192.36M-$107.70M(-127.22%)Summary
- As of today, MLYS annual EBITDA is -$192.36 million, with the most recent change of -$107.70 million (-127.22%) on December 31, 2024.
- During the last 3 years, MLYS annual EBITDA has fallen by -$172.98 million (-892.52%).
- MLYS annual EBITDA is now -5709.73% below its all-time high of -$3.31 million, reached on December 1, 2020.
Performance
MLYS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$46.73M-$2.30M(-5.17%)Summary
- As of today, MLYS quarterly EBITDA is -$46.73 million, with the most recent change of -$2.30 million (-5.17%) on June 30, 2025.
- Over the past year, MLYS quarterly EBITDA has dropped by -$1.57 million (-3.48%).
- MLYS quarterly EBITDA is now -621.25% below its all-time high of -$6.48 million, reached on June 1, 2022.
Performance
MLYS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$203.01M-$1.57M(-0.78%)Summary
- As of today, MLYS TTM EBITDA is -$203.01 million, with the most recent change of -$1.57 million (-0.78%) on June 30, 2025.
- Over the past year, MLYS TTM EBITDA has dropped by -$68.51 million (-50.94%).
- MLYS TTM EBITDA is now -2766.14% below its all-time high of -$7.08 million, reached on December 1, 2021.
Performance
MLYS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MLYS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -127.2% | -3.5% | -50.9% |
| 3Y3 Years | -892.5% | -621.3% | -1396.9% |
| 5Y5 Years | -5709.7% | -559.8% | -2766.1% |
MLYS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -892.5% | at low | -529.5% | +22.2% | -867.4% | at low |
| 5Y | 5-Year | -5709.7% | at low | -621.3% | +22.2% | -2766.1% | at low |
| All-Time | All-Time | -5709.7% | at low | -621.3% | +22.2% | -2766.1% | at low |
MLYS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$46.73M(-5.2%) | -$203.01M(-0.8%) |
| Mar 2025 | - | -$44.43M(+14.1%) | -$201.44M(-4.7%) |
| Dec 2024 | -$192.36M(-127.2%) | -$51.75M(+13.9%) | -$192.36M(-14.3%) |
| Sep 2024 | - | -$60.09M(-33.1%) | -$168.32M(-25.1%) |
| Jun 2024 | - | -$45.16M(-27.7%) | -$134.50M(-28.0%) |
| Mar 2024 | - | -$35.35M(-27.6%) | -$105.07M(-24.1%) |
| Dec 2023 | -$84.66M | -$27.71M(-5.5%) | -$84.66M(-26.4%) |
| Sep 2023 | - | -$26.27M(-67.0%) | -$66.95M(-39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$15.73M(-5.3%) | -$48.10M(-23.8%) |
| Mar 2023 | - | -$14.94M(-49.3%) | -$38.85M(-62.5%) |
| Dec 2022 | -$31.48M(-62.4%) | -$10.01M(-34.8%) | -$23.91M(-13.9%) |
| Sep 2022 | - | -$7.42M(-14.6%) | -$20.98M(-54.7%) |
| Jun 2022 | - | -$6.48M(+8.5%) | -$13.56M(-91.5%) |
| Dec 2021 | -$19.38M(-485.4%) | - | - |
| Dec 2021 | - | -$7.08M | -$7.08M |
| Dec 2020 | -$3.31M | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Mineralys Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of MLYS is -$192.36M
What is the all-time high annual EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual EBITDA is -$3.31M
What is Mineralys Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, MLYS annual EBITDA has changed by -$107.70M (-127.22%)
What is Mineralys Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of MLYS is -$46.73M
What is the all-time high quarterly EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly EBITDA is -$6.48M
What is Mineralys Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, MLYS quarterly EBITDA has changed by -$1.57M (-3.48%)
What is Mineralys Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of MLYS is -$203.01M
What is the all-time high TTM EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM EBITDA is -$7.08M
What is Mineralys Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, MLYS TTM EBITDA has changed by -$68.51M (-50.94%)